1. Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer
   K. Jakubowska et al, 2015, Respiratory Carcinogenesis CrossRef
2. Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms
   Yan-Jun Song et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
3. Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
   N. Woldmar et al, 2023, ESMO Open CrossRef
4. Investigation of phosphoproteome in RAGE signaling
   Kedar B. Batkulwar et al, 2015, PROTEOMICS CrossRef
5. Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells
   Wataru Arai et al, 2023, Oncotarget CrossRef
6. MicroRNA-181b is downregulated in non-small cell lung cancer and inhibits cell motility by directly targeting HMGB1
   Yun Liu et al, 2016, Oncology Letters CrossRef
7. The role of high‐mobility group protein box 1 in lung cancer
   Xiao‐Jin Wu et al, 2018, Journal of Cellular Biochemistry CrossRef
8. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
   Eyaldeva C. Vijayakumar et al, 2019, Current Drug Targets CrossRef
9. Role of HMGB1 and its associated signaling pathways in human malignancies
   Sourour Idoudi et al, 2023, Cellular Signalling CrossRef
10. Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
    Satoshi Nakao et al, 2020, Respiratory Medicine CrossRef
11. Smoking Exposure Induces Human Lung Endothelial Cell Adaptation to Apoptotic Stress
    Daniela N. Petrusca et al, 2014, American Journal of Respiratory Cell and Molecular Biology CrossRef
12. High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer
    Yanqiu Yue et al, 2017, Tumor Biology CrossRef
13. HMGB1 mediates hyperglycaemia‐induced cardiomyocyte apoptosis via ERK/Ets‐1 signalling pathway
    Wen‐Ke Wang et al, 2014, Journal of Cellular and Molecular Medicine CrossRef
14. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer
    Anlin Feng et al, 2016, Oncotarget CrossRef
15. Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression
    Efthalia Angelopoulou et al, 2016, Journal of Molecular Medicine CrossRef
16. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo
    JING ZHANG et al, 2014, International Journal of Oncology CrossRef
17. Downregulation of high mobility group protein box‑1 resensitizes ovarian cancer cells to carboplatin
    Wen Shu, 2018, Oncology Letters CrossRef
18. Lung Adenocarcinoma Complicated by Trousseau's Syndrome Successfully Treated by a Combination of Anticoagulant Therapy and Chemotherapy
    Yutaka Yoshii et al, 2014, Internal Medicine CrossRef
19. Effect of ulinastatin on the expression and distribution of high mobility group box 1 in human colon carcinoma cells in vitro
    YUNHUA WANG et al, 2015, Molecular Medicine Reports CrossRef
20. Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro
    ZHENG-HUA HUANG et al, 2015, Molecular Medicine Reports CrossRef
21. High Mobility Group Box Protein 1 Serves as a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-κB-Dependent Manner
    Xiaojin Wu et al, 2018, BioMed Research International CrossRef